期刊文献+

浅谈艾森门格综合征的编码体会

DISCUSS ON THE EXPERIENCE IN CODING EISENMENGERS SYNDROME
下载PDF
导出
摘要 我国实行国际疾病分类(ICD-10)非常重要:①便于国内与国际交流;②医疗、科研与教学病案资料的检索;③医院管理信息的提取;④医院等级评审;⑤临床路径应用;⑥临床重点学科申报;⑦医保管理、医疗付款等方面。所以编码人员必须根据临床诊断结合ICD-10编码原则,正确编码。笔者从ICD-10第二版索引中发现,以艾森门格尔命名的疾病编码有两个,分别分类到第九章循环系统疾病与第十七章先天性畸形、变形和染色体异常两章。两者的区别与编码选择使编码者感到困惑,因此,查阅了一些有关资料,对此疾病的编码进行探讨。 It is very important to implement International Disease Classification (ICD - 10) in China, to pro- vide a platform to home and abroad, to retrieve materials among medical, science and case teaching, to extract hospi- tal management information, to hospital appraisal, to clinical application, to key disciplinary application, to medical insurance management and medical payment and so on. Therefore, coders should achieve the correct coding following clinical diagnosis and principles of ICD - 10. We found in ICD - 10 ( second edition) that there are two codes named by Eisenmenger syndrome, they are separately classified into Chapter 9 (disease of circulatory system) and Chapter 17 (Congenital malformation, deformation and chromosome abnormality). The difference of two codings and selection between them brings coder at fault. So in this essay we will analyze Eisenmenger syndrome to tell the difference be- tween them and help coders to make a right decision on code selection.
出处 《现代医院》 2013年第6期140-141,共2页 Modern Hospitals
关键词 艾森门格尔 综合征 编码 探讨 Eisenmenger, Syndrome, Encoding, Analyze
  • 相关文献

参考文献5

二级参考文献21

  • 1张建华,刘惠俐,富丽芳.呼吸康复训练对老年慢性阻塞性肺部疾病病人生活质量的影响[J].中华护理杂志,2004,39(7):504-506. 被引量:103
  • 2庄曼茹.慢性肺源性心脏病合并心力衰竭的临床研究[J].实用心脑肺血管病杂志,2010,18(12):1827-1828. 被引量:11
  • 3Badesch DB,Champion HC,Sanchez MA,et al.Diagnosis and as-sessment of pulmonary arterial hypertension[J].J Am Coll Cardi-ol,2009,54(1 Suppl):S55-S66.
  • 4Olschewski H,Hoeper MM,Behr J,et al.Long-term therapy withinhaled iloprost in patients with pulmonary hypertension[J].Re-spir Med,2010,104(5):731-740.
  • 5Baysal A,Bilsel S,Bulbul OG,et al.Comparison of the usage of in-travenous iloprost and nitroglycerin for pulmonary hypertension dur-ing valvular heart surgery[J].Heart Surg Forum,2006,9(1):E536-E542.
  • 6Fuso L,Baldi F,Di Perna A.Therapeutic strategies in pulmonaryhypertension[J].Front Pharmacol,2011,2:21.
  • 7Rosenkranzl S.Pulmonary hypertension:current diagnosis andtreatment[J].Clin Res Cardiol,2007,96(8):527-541.
  • 8Wong RC,Koh GM,Choong PH,et al.Oral sildenafil therapy im-proves health-related quality of Life and functional status in pulmo-nary arterial hypertension[J].Int J Cardiol,2007,119(3):400-402.
  • 9Lu XL,Xiong CM,Shan GL,et al.Sildenafil therapy for pulmonaryhypertension:a prospective study[J].Zhonghua Jie He He Hu XiZa Zhi,2011,34(6):419-423.
  • 10Mclaughlin VV,Sitbon O,Badesch DB,et al.Survival with first-line bosentan in patients with primary pulmonary hypertension[J].Eur Respir J,2005,25(2):244-249.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部